A startup founded by a University of Arizona (UA) professor to bring to market the flexible carbon fiber fabric he invented to repair hard-to-set fractured bones received funding from Tucson-based UAventure Capital. The inventor, Hamid Saadatmanesh, licensed the technology from the university and is developing it through his new company, Medicarbone Inc.

Corvia Medical Inc. is enrolling patients in a 100-site multinational study of its Interatrial Shunt Device that will measure traditional heart failure endpoints as well as biosensor data transmitted to the cloud for analysis by Napier, Ill.-based Physiq's artificial intelligence analytics. The trial will evaluate Tewksbury, Mass.-based Corvia's device in heart failure with preserved and mid-range ejection fraction.

The FDA granted breakthrough device status to Prescient Metabiomics' Lifekit Prevent colorectal neoplasia test. Prescient Metabiomics is a subsidiary of Carlsbad, Calif.-based Prescient Medicine Holdings Inc.

Evaxion Biotech A/S is leveraging two artificial intelligence (AI) platforms to quickly identify targets for cancer immunotherapies and infectious diseases. 

Researchers from the Swiss École Polytechnique Fédérale de Lausanne (EPFL) and the University Medical Center Utrecht in the Netherlands have developed a bioprinting process that allows simultaneous production of the entire volume of complex shapes, providing much greater flexibility and faster production than layer-by-layer 3D printing. Details on the process, called volumetric printing, and printer were published in Advanced Materials.